The FTC said the deal would hinder innovation for medical devices used to treat a serious heart condition known as aortic regurgitation.

Nominations are open for the 2nd annual Best in Business Awards, which honor the vendors, suppliers and partners powering the healthcare industry.

Macroeconomic factors such as interest rates and tariffs have put widespread pressure on private equity deals.